Mutual of America Capital Management’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.9M Sell
572,729
-2,734
-0.5% -$60.4K 0.12% 161
2025
Q4
$13.9M Sell
575,463
-55,128
-9% -$1.44M 0.15% 112
2025
Q3
$16.1M Sell
630,591
-7,782
-1% -$185K 0.17% 89
2025
Q2
$13.8M Buy
638,373
+115,963
+22% +$2.61M 0.15% 112
2025
Q1
$11.9M Buy
522,410
+473
+0.1% +$12.5K 0.14% 125
2024
Q4
$13.5M Buy
521,937
+124,165
+31% +$3.09M 0.15% 110
2024
Q3
$9.96M Sell
397,772
-3,144
-0.8% -$74.3K 0.1% 174
2024
Q2
$8.59M Buy
+400,916
New +$7.78M 0.09% 199
2022
Q4
Sell
-6,781
Closed -$154K 1469
2022
Q3
$154K Buy
6,781
+1,653
+32% +$35.4K ﹤0.01% 1431
2022
Q2
$71K Buy
5,128
+808
+19% +$11.9K ﹤0.01% 1561
2022
Q1
$98K Buy
4,320
+316
+8% +$8.32K ﹤0.01% 1519
2021
Q4
$149K Buy
4,004
+126
+3% +$5.41K ﹤0.01% 1429
2021
Q3
$164K Buy
+3,878
New +$187K ﹤0.01% 1396

Other funds holding BLFS

Mutual of America Capital Management's BLFS Position: Q1 2026 in Review

Mutual of America Capital Management reduced its BioLife Solutions (BLFS) stake by 0.48% in Q1 2026, selling an estimated $60.4K and leaving 572,729 shares worth $10.9M. The position accounts for 0.12% of the portfolio, ranked #161.

Mutual of America Capital Management first reported a position in BLFS in Q3 2021 and has held it in 13 quarters since. The position peaked at $16.1M in Q3 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • Mutual of America Capital Management held 572,729 shares of BioLife Solutions worth $10.9M as of Q1 2026.
  • Mutual of America Capital Management sold 2,734 BioLife Solutions shares in Q1 2026, an estimated $60.4K.
  • BioLife Solutions made up 0.12% of Mutual of America Capital Management's portfolio in Q1 2026, its #161 holding.
  • Mutual of America Capital Management first reported a position in BioLife Solutions in Q3 2021 and has held it in 13 quarters since.
  • Mutual of America Capital Management's BioLife Solutions position peaked at $16.1M in Q3 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Mutual of America Capital Management's 13F filing for Q1 2026, filed 7 May 2026.